Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Covington
Daiichi Sankyo
Citi
Chinese Patent Office
Accenture
Julphar
Fuji
Cerilliant

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,174,442

« Back to Dashboard

Which drugs does patent 6,174,442 protect, and when does it expire?

Patent 6,174,442 protects VELPHORO and is included in one NDA.

This patent has twenty-two patent family members in twenty countries.
Summary for Patent: 6,174,442
Title: Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent
Abstract:An adsorbent for phosphate from aqueous medium, particularly for inorganic phosphate or phosphate bound to foodstuffs from body fluids or foodstuffs, which contains beta-iron hydroxide stabilized by carbohydrates and/or by humic acid.
Inventor(s): Geisser; Peter (St. Gallen, CH), Philipp; Erik (St. Gallen, CH)
Assignee: Vifor (International) AG (St. Gallen, SE)
Application Number:09/077,944
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation;

Drugs Protected by US Patent 6,174,442

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y CONTROL OF PHOSPHOROUS LEVELS IN PATIENTS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,174,442

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 47 356Dec 19, 1995
PCT Information
PCT FiledDecember 19, 1996PCT Application Number:PCT/EP96/05695
PCT Publication Date:June 26, 1997PCT Publication Number: WO97/22266

International Patents Family Members for US Patent 6,174,442

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain 2171758 ➤ Subscribe
Brazil 9612138 ➤ Subscribe
Canada 2240668 ➤ Subscribe
Germany 19547356 ➤ Subscribe
Germany 59608089 ➤ Subscribe
Denmark 0868125 ➤ Subscribe
European Patent Office 0868125 ➤ Subscribe C300710 Netherlands ➤ Subscribe
European Patent Office 0868125 ➤ Subscribe PA2015003 Lithuania ➤ Subscribe
European Patent Office 0868125 ➤ Subscribe CA 2015 00007 Denmark ➤ Subscribe
European Patent Office 0868125 ➤ Subscribe 15C0018 France ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Johnson and Johnson
Boehringer Ingelheim
Novartis
Daiichi Sankyo
Mallinckrodt
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot